Impact of Endoscopic Sleeve Gastroplasty in Non-alcoholic Fatty Liver Disease: a Systematic Review and Meta-analysis
The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
Non-alcoholic fatty liver disease (NAFLD) is the most common cause of liver disease worldwide. Endoscopic sleeve gastroplasty (ESG) has proven to be feasible, safe, and effective in the management of obesity. We performed the first systematic review and meta-analysis evaluating NAFLD and other metabolic parameters 12 months post-ESG. Four observational studies with a total of 175 patients were included. The results showed a significant (p 2 in BMI (95% CI - 8.11, - 4.52), 47.97% in EWL (95% CI - 49.10, - 46.84), and 0.51% in HbA1c (95% CI - 0.90, - 0.12). ESG improves liver parameters, provides weight loss, and reduces HbA1c levels in patients suffering from NAFLD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Another meta-analysis confirmed improved metabolic markers and liver function 12 months post-ESG [82].”
From Impact of Bariatric Surgery and Endoscopic Therapies on Liver Health in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Review (2025) · cites this paper as [82]
In the citing paper
“Patients also experienced ALT reductions of 6.32 U/L and a total weight loss of 17.28% [82].”
From Impact of Bariatric Surgery and Endoscopic Therapies on Liver Health in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Review (2025) · cites this paper as [82]
In the citing paper
“A systematic review and meta-analysis involving 175 patients found ESG significantly reduced the NAFLD fibrosis score by 0.5 points and hepatic steatosis index by 4.85 points.”
From Impact of Bariatric Surgery and Endoscopic Therapies on Liver Health in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Review (2025) · cites this paper as [82]
In the citing paper
“A systematic review and meta-analysis involving 175 patients found ESG significantly reduced the NAFLD fibrosis score by 0.5 points and hepatic steatosis index by 4.85 points.”
From Impact of Bariatric Surgery and Endoscopic Therapies on Liver Health in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Review (2025) · cites this paper as [82]
In the citing paper
“Patients also experienced ALT reductions of 6.32 U/L and a total weight loss of 17.28% [82].”
From Impact of Bariatric Surgery and Endoscopic Therapies on Liver Health in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Review (2025) · cites this paper as [82]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139 · cited 1×
“Heterogeneity was calculated using the Higgins method (I2) [15].”
MethodGRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
Sterne, J. A., Hernán, M. A., Reeves, B. C., Savović, J., Berkman, N. D., Viswanathan, M., Henry, D., Altman, D. G., Ansari, M. T., Boutron, I., et al. (2016) · BMJ · doi:10.1136/bmj.i4919 · Cited by 20,329 · cited 1×
“The risk of bias was assessed by the Risk of Bias in Nonrandomized Studies of Interventions (ROBINS-I) tool [12].”
MethodLiberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gotzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · BMJ · doi:10.1136/bmj.b2700 · Cited by 17,648
Younossi, Z. M., Koenig, A. B., Abdelatif, D., Fazel, Y., Henry, L., & Wymer, M. (2016) · Hepatology · doi:10.1002/hep.28431 · Cited by 10,781
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-4-200908180-00136 · Cited by 10,349 · cited 1×
“This systematic review and meta-analysis were performed in conformity with the recommendations from the Preferred Reporting Items for Systematic Reviews and Metaanalysis (PRISMA) guidelines [11].”
MethodChalasani, N., Younossi, Z., Lavine, J. E., Charlton, M., Cusi, K., Rinella, M., Harrison, S. A., Brunt, E. M., & Sanyal, A. J. (2018) · Hepatology · doi:10.1002/hep.29367 · Cited by 7,239 · cited 4×
“Consequently, more data are needed to confirm if ESG is effective to interrupt the evolution of liver cirrhosis and the development of HCC. HSI is also a NIT, which evaluates earlier stages of NAFLD, being a practical and inexpensive method for screening steatosis with reasonable accuracy [23].”
BackgroundInfluentialLifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery
Sjöström, L., Lindroos, A.-K., Peltonen, M., Torgerson, J., Bouchard, C., Carlsson, B., Dahlgren, S., Larsson, B., Narbro, K., Sjöström, C. D., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035622 · Cited by 4,457
Mechanisms of NAFLD development and therapeutic strategies
Friedman, S. L., Neuschwander-Tetri, B. A., Rinella, M., & Sanyal, A. J. (2018) · Nature Medicine · doi:10.1038/s41591-018-0104-9 · Cited by 4,354
Chalasani, N., Younossi, Z., Lavine, J. E., Diehl, A. M., Brunt, E. M., Cusi, K., Charlton, M., & Sanyal, A. J. (2012) · Hepatology · doi:10.1002/hep.25762 · Cited by 3,803
Research works printed but not linked: 1
- EspinetColl E, Vila Lolo C, DíazGalán P, et al. Bariatric and metabolic endoscopy in the handling of fatty liver disease. A new emerging approach? Rev Espanola Enfermedades Dig Organo Of Soc Espanola Patol Dig. 2019;111:283–93.
Cited by
Lara, C., & Romero‐Gómez, M. (2024) · European Cardiology Review · doi:10.15420/ecr.2023.34 · Cited by 25
Obesity Is Associated with Fatty Liver and Fat Changes in the Kidneys in Humans as Assessed by MRI
Raphael, H., Klang, E., Konen, E., Inbar, Y., Leibowitz, A., Frenkel‐Nir, Y., Apter, S., & Grossman, E. (2024) · Nutrients · doi:10.3390/nu16091387 · Cited by 18
“Regarding the liver, two recent studies showed that weight reduction improved parameters of a fatty liver [34,35].”
BackgroundTasabehji, D., Saleh, S., & Mokadem, M. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14124012 · Cited by 14
Impact of Weight Loss on Metabolic Dysfunction Associated Steatohepatitis and Hepatic Fibrosis
Takawy, M., & Abdelmalek, M. F. (2025) · Current Diabetes Reports · doi:10.1007/s11892-025-01579-1 · Cited by 14
“%) and comparison among different types of EBTs, including ESG, was not feasible [172, 173].”
Hanscom, M. H., Baig, M. U., Wright, D., Baqain, L. E., Johnson, K. E., Kumbhari, V., Sullivan, S. A., Dayyeh, B. A., Mahadev, S., Newberry, C. A., et al. (2025) · Obesity Surgery · doi:10.1007/s11695-025-07842-4 · Cited by 14
Metadata
- Authors
- Nunes, B. C. M., de Moura, D. T. H., Kum, A. S. T., de Oliveira, G. H. P., Hirsch, B. S., Ribeiro, I. B., Gomes, I. L. C., de Oliveira, C. P. M., Mahmood, S., Bernardo, W. M., & de Moura, E. G. H.
- Affiliations
- Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (BR)
- Beth Israel Deaconess Medical Center (US)
- Corresponding author
- Ribeiro, Igor Braga
- ORCID
- Venue
- Obesity Surgery
- Published
- 2023-08-04
- Volume
- 33
- Issue
- 9
- Pages
- 2917-2926
- ISSN
- 0960-8923 (ISSN-L)
- 1708-0428
- OpenAlex
- W4385564638
- Cited by
- 41
- References
- 34
- Citations by year
- 2026: 9 · 2025: 23 · 2024: 7 · 2023: 2
- FWCI
- 2.66
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Obesity Surgery (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Surgery › Minimally Invasive Surgical Techniques
- Keywords
- endoscopic sleeve gastroplasty, non-alcoholic fatty liver disease
- MeSH terms
- Glycated Hemoglobin, Humans, Obesity, Morbid, Gastroplasty, Treatment Outcome, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Impact of Endoscopic Sleeve Gastroplasty in Non-alcoholic Fatty Liver Disease: a Systematic Review and Meta-analysis. https://app.cochat.ai/papers/10.1007/s11695-023-06747-4
- The paper
- Nunes, B. C. M., de Moura, D. T. H., Kum, A. S. T., de Oliveira, G. H. P., Hirsch, B. S., Ribeiro, I. B., Gomes, I. L. C., de Oliveira, C. P. M., Mahmood, S., Bernardo, W. M., & de Moura, E. G. H. (2023). Impact of Endoscopic Sleeve Gastroplasty in Non-alcoholic Fatty Liver Disease: a Systematic Review and Meta-analysis. Obesity Surgery. https://doi.org/10.1007/s11695-023-06747-4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.